
DEXCOM INC
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
Dexcom makes continuous glucose monitoring (CGM) systems that let people with diabetes track their blood sugar levels in real time via a sensor worn on the body paired with a receiver or smartphone app. The company sells its devices to patients, healthcare providers, and partners worldwide, generating revenue primarily through sales of sensors, transmitters, and receivers.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Brown Michael JonEVP Chief Legal Compliance Off | Sell | $145K | 1,700at $85.48 | Oct 15, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable DXCM activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.